poisar

Stock

Solventum Corporation SOLV

$90.95-0.64%

Overview

SOLV market data

Price History

SOLV price chart · 1M
O
90.81
H
92.24
L
90.81
C
90.95
Vol
37,927.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$90.81
Previous Close
$91.54
Day High
$92.24
Day Low
$90.81
52 Week High
$92.71
52 Week Low
$65.54
7 Day Return
+2.59%
30 Day Return
+5.58%
90 Day Return
+21.33%
1 Year Return
+36.75%
Daily Notional Volume
$3.4M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
10.26
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$8.88
Diluted earnings per share over the trailing twelve months.
Beta
0.45
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
17.3%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$62.38 – $92.71
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $14.7B · P/B 2.72 · P/S 1.77.

Company News

10 captured
UBS Maintains Buy on Solventum, Raises Price Target to $101Benzinga · Aug 6, 2026, 6:52 PM
Solventum shares are trading lower after the company reported Q2 financial results. The stock initially rallied yesterday after the market closed, but it has since reversed.Benzinga · Aug 6, 2026, 6:30 PM
Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105Benzinga · Aug 6, 2026, 4:46 PM
Wedbush Maintains Outperform on Solventum, Raises Price Target to $101Benzinga · Aug 6, 2026, 3:44 PM
Keybanc Maintains Overweight on Solventum, Raises Price Target to $102Benzinga · Aug 6, 2026, 2:41 PM
Stifel Maintains Buy on Solventum, Raises Price Target to $100Benzinga · Aug 6, 2026, 2:24 PM
BTIG Maintains Buy on Solventum, Raises Price Target to $95Benzinga · Aug 6, 2026, 9:49 AM
Solventum Plans To Separate Its Health Information Systems Operations As Part Of Its Portfolio Optimization StrategyBenzinga · Aug 5, 2026, 8:53 PM
Solventum shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance above estimates.Benzinga · Aug 5, 2026, 8:42 PM
Solventum Q2 Adj. EPS $2.55 Beats $1.91 Estimate, Sales $2.209B Beat $2.156B EstimateBenzinga · Aug 5, 2026, 8:19 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock